[HTML][HTML] Efficacy of tocilizumab in patients hospitalized with Covid-19

…, A Zafar, ZD Drobni, MB Bolster, M Kohler… - … England Journal of …, 2020 - Mass Medical Soc
Background The efficacy of interleukin-6 receptor blockade in hospitalized patients with
coronavirus disease 2019 (Covid-19) who are not receiving mechanical ventilation is unclear. …

[HTML][HTML] Pilot point-of-care ultrasound curriculum at Harvard Medical School: early experience

…, A Liteplo, H Kimberly, MJ Kohler - Western Journal of …, 2016 - ncbi.nlm.nih.gov
Methods This was a pilot study to introduce ultrasonography into the Harvard Medical School
curriculum to first-and second-year medical students. Didactic and hands-on sessions …

Adverse effects of topical nonsteroidal antiinflammatory drugs in older adults with osteoarthritis: a systematic literature review

UE Makris, MJ Kohler, L Fraenkel - The Journal of rheumatology, 2010 - jrheum.org
Objective. To systematically review the literature on reported adverse effects (AE) associated
with use of topical nonsteroidal antiinflammatory drugs (NSAID) in older adults with …

The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease

…, A So, TL Jansen, MJ Kohler… - Arthritis & …, 2023 - Wiley Online Library
Objective Calcium pyrophosphate deposition (CPPD) disease is prevalent and has diverse
presentations, but there are no validated classification criteria for this symptomatic arthritis. …

Imaging features of calcium pyrophosphate deposition disease: consensus definitions from an international multidisciplinary working group

…, G Filippou, A Iagnocco, MJ Kohler… - Arthritis care & …, 2023 - Wiley Online Library
Objective To develop definitions for imaging features being considered as potential classification
criteria for calcium pyrophosphate deposition (CPPD) disease, additional to clinical …

Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: a single center experience

…, DP Lawrence, EM Miloslavsky, MJ Kohler… - Seminars in arthritis and …, 2019 - Elsevier
Background The use of immune checkpoint inhibition (ICI) has revolutionized cancer treatment.
However, these medications are associated with significant and potentially debilitating …

The provisional OMERACT ultrasonography score for giant cell arteritis

…, KK Keller, HI Keen, TA Kermani, MJ Kohler… - Annals of the …, 2023 - ard.bmj.com
Objectives To develop an Outcome Measures in Rheumatology (OMERACT) ultrasonography
score for monitoring disease activity in giant cell arteritis (GCA) and evaluate its metric …

Identifying potential classification criteria for calcium pyrophosphate deposition disease: item generation and item reduction

…, A Iagnocco, TL Jansen, MJ Kohler… - Arthritis care & …, 2022 - Wiley Online Library
Objective Classification criteria for calcium pyrophosphate deposition (CPPD) disease will
facilitate clinical research on this common crystalline arthritis. Our objective was to report on …

Temporal trends and outcomes among patients admitted for immune-related adverse events: a single-center retrospective cohort study from 2011 to 2018

…, D Okin, BD Medoff, M Nasrallah, MJ Kohler… - The …, 2021 - academic.oup.com
Background The aim of this study was to characterize severe immune-related adverse events
(irAEs) seen among hospitalized patients and to examine risk factors for irAE admissions …

[HTML][HTML] Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer

…, BD Medoff, M Nasrallah, MJ Kohler… - … for ImmunoTherapy of …, 2021 - ncbi.nlm.nih.gov
Original research: Effect of a multidisciplinary Severe Immunotherapy Complications Service
on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer - PMC …